Does Rallies show Form 4 insider transactions for LMAT?

Yes. Rallies tracks LMAT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is LMAT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for LMAT. It does not provide personalized investment advice.

LMAT (LeMaitre Vascular, Inc.) Stock Analysis - Insider Trades

LeMaitre Vascular, Inc. (LMAT) is a publicly traded Healthcare sector company. As of May 21, 2026, LMAT trades at $100.60 with a market cap of $2.30B and a P/E ratio of 36.90. LMAT moved +0.22% today. Year to date, LMAT is +23.83%; over the trailing twelve months it is +19.68%. Its 52-week range spans $71.42 to $118.01. Analyst consensus is strong buy with an average price target of $122.14. Rallies surfaces LMAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading LMAT stock inside the company?

Recent LMAT insider activity includes LeMaitre George W sold 27.88K, Kamke Trent G sold 2.93K, LeMaitre George W sold 18.60K, Ross Bridget A sold 5.04K, and Jasinski Lawrence J sold 3.94K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

LMAT Key Metrics

Key financial metrics for LMAT
Metric	Value
Price	$100.60
Market Cap	$2.30B
P/E Ratio	36.90
EPS	$2.76
Dividend Yield	0.25%
52-Week High	$118.01
52-Week Low	$71.42
Volume	0
Avg Volume	0
Revenue (TTM)	$256.28M
Net Income	$62.40M
Gross Margin	72.39%

Recent LMAT Insider Trades

LeMaitre George W sold 27.88K (~$3.03M) on May 8, 2026.
Kamke Trent G sold 2.93K (~$313.29K) on May 8, 2026.
LeMaitre George W sold 18.60K (~$2.00M) on May 7, 2026.
Ross Bridget A sold 5.04K (~$560.37K) on May 7, 2026.
Jasinski Lawrence J sold 3.94K (~$433.73K) on May 7, 2026.

Latest LMAT News

LeMaitre to Present at May 13 Healthcare Conference, Wins Zacks #2 Buy — May 7, 2026
LeMaitre Vascular Q1 Sales Rise 11%, EPS Up 42%, Raises 2026 Guidance — May 5, 2026
LeMaitre Vascular Trades Below 10-Year P/E Average, Offers 11–16% Return Potential — Feb 28, 2026
LeMaitre Vascular Q4 Revenue Up 15.7% and EPS Beats, Shares Jump 16.8% — Feb 26, 2026

LMAT Analyst Consensus

8 analysts cover LMAT: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $122.14.

Common questions about LMAT

Who is trading LMAT stock inside the company?: Recent LMAT insider activity includes LeMaitre George W sold 27.88K, Kamke Trent G sold 2.93K, LeMaitre George W sold 18.60K, Ross Bridget A sold 5.04K, and Jasinski Lawrence J sold 3.94K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for LMAT?: Yes. Rallies tracks LMAT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is LMAT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for LMAT. It does not provide personalized investment advice.